Please login to the form below
autoimmune disease
This page shows the latest autoimmune disease news and features for those working in and with pharma, biotech and healthcare.
Apellis jumps as pegcetacoplan tops Alexion’s Soliris in PNH trial
Shares shot up more than 50% in wake of announcement. Apellis has new data showing that its pegcetacoplan drug outperformed Alexion’s market leading Soliris in rare disease paroxysmal nocturnal haemoglobinuria ... PNH). The head-to-head PEGASUS study
Latest news
-
Sanofi’s sutimlimab set for filing in rare autoimmune anaemia next year
Sutimlimab – a first-in-class selective inhibitor of complement C1s – has hit the mark in cold agglutinin disease (CAD), a rare, autoimmune form of haemolytic anaemia that causes blood clots, leading ... to invest more in this area while reining in
-
Roche’s Soliris rival satralizumab scores in phase 3 study
NMOSD is an autoimmune disease that affects the central nervous system, and is characterised by progressive damage to neurons during relapses that can lead to blindness and paralysis. ... This group reflects a real-world population of adolescents and
-
US, EU regulators start review of Roche’s Soliris rival satralizumab
Sets up a possible market clash with Alexion next year. The FDA and EMA have kicked off their reviews of Roche’s satralizumab for rare disease neuromyelitis optica spectrum disorder (NMOSD), ... NMOSD is an autoimmune disease of the central nervous
-
Roche wins FDA breakthrough for Gazyva in lupus nephritis
The condition is particularly hard-to-treat – it is a form of the autoimmune disease lupus that causes the kidneys to become inflamed, leading to a high risk of end-stage ... There are currently no FDA-approved drugs for the disease – this means that
-
Boehringer bags FDA OK for Ofev in rare lung disease ILD
First drug approved for condition. Boehringer Ingelheim’s Ofev has become the first drug approved by the FDA for a lung disease that afflicts patients with systemic sclerosis, a rare autoimmune ... Scleroderma is a rare disease that causes tissue
More from news
Approximately 3 fully matching, plus 67 partially matching documents found.
Latest Intelligence
-
30 Women Leaders in UK Healthcare (part 2)
ecosystem. In her 25-plus years in the sector, her investments have resulted in the launch of six drugs, spanning inflammatory and autoimmune disease and cancer.
-
Managing medication non-adherence
Autoimmune conditions such as Crohn’s disease can flare up through an imbalance of things like stress, lack of sleep or overworking - not just as a direct consequence of nonadherence to
-
Reaching new heights
Transformative medicine use. The overwhelming inertia in medicine use - where 97% of medicines used have been available for more than ten years - masks the contribution from transformative disease treatments, orphan drugs ... Disease treatments in 2020
-
Pharma deals during May 2014
Lumena develops oral products for treating liver disease and has two oral inhibitors of the apical sodium-dependent bile acid transporter (ASBT) in phase II to improve liver function. ... MGD010 a B-cell targeted monoclonal antibody for treatment of
-
The distressing impact of rare diseases
The report found that the economic impact of a rare disease can be truly devastating. ... A UK patient with mixed connective tissue disease (an autoimmune rare disease which has the signs and symptoms of lupus, scleroderma, polymyositis, and rheumatoid
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease
-
Akari Therapeutics strengthens board
His expertise has seen him led transactions across a broad span of deal-types, geographies, and therapeutic disease areas and he brings experience in business and corporate development, finance, marketing and ... As Akari continues its mission to develop
-
David Horn Solomon takes the helm of Akari Therapeutics
biopharma as it focuses on the development and commercialisation of orphan autoimmune and inflammatory disease treatments.
-
Caldan Therapeutics appoints CEO
Dr Payton joins the metabolic disease specialist - a spin-out company from the Universities of Glasgow and Southern Denmark - from MAPBiotech, where he has served as chief executive officer since 2014. ... He co-founded autoimmune disease-focused Orca
-
Santhera CEO Klaus Schollmeier joins SuppreMol
In his new position at autoimmune disease specialists SuppreMol, Schollmeier succeeds Professor Peter Buckell who retires. ... He said: "The company has a very promising product candidate for the treatment of autoimmune diseases in phase II clinical
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
PANDAS/PANS Awareness: A parent’s story
parent of a son recently diagnosed with PANDAS (paediatric autoimmune neuropsychiatric disorder associated with Streptococcus)…. ... As PANDAS is an autoimmune disease that leads to inflammation in the basal ganglia region of the brain, the symptoms
-
Innovative approaches in the treatment of multiple sclerosis
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In RRMS symptoms are intermittent but relapses gradually become more frequent, severe and
-
Innovative approaches in the treatment of multiple sclerosis
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In RRMS symptoms are intermittent but relapses gradually become more frequent, severe and
-
The Biosimilar Challenge
Herceptin, Avastin, Rituximab and Erbitux) and autoimmune disease (e.g. Humira, Enbrel, Remicade, MabThera and RoActemra to name a few).
-
THE OTHER SIDE OF… CROHN’S DISEASE
Meet Irene. Like millions of others worldwide (and an estimated 115, 000 in the UK), Irene suffers from Crohn’s disease, an autoimmune disorder that causes inflammation in the gut and ... She believes that they follow a “by-the-book” mentality, not
More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.
Featured jobs
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
-
Consultant
-
competitive salary
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Account Director or Senior Account Director
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Vice President
-
Competitive Salary Offered
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
- Moving annual total (MAT)
- NantKwest rockets on promising pancreatic cancer data
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
- NantKwest rockets on promising pancreatic cancer data
- Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer
- Novo Nordisk gets MACE prevention claim for Ozempic in US
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- How do companies prepare for reimbursement?
- Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
- Integrating electronic health records into clinical trials
- How organisations are working to realise the research potential of EHRs...
- Keeping up the fight against HIV and using the lessons to tackle other threats
- Danny Buckland interviews Gilead’s Mike Elliott...
Quick links
Infographics
